Liquidia Corp Files 8-K on Operations and Financials
Ticker: LQDA · Form: 8-K · Filed: Mar 13, 2024
Sentiment: neutral
Topics: operations, financials, disclosure
TL;DR
Liquidia Corp dropped an 8-K detailing its financials and operations as of March 13, 2024.
AI Summary
Liquidia Corporation filed an 8-K on March 13, 2024, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 419 Davis Drive, Suite 100, Morrisville, North Carolina.
Why It Matters
This 8-K filing provides crucial updates on Liquidia Corporation's financial health and operational performance, which are important for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of operational and financial information, not indicating any immediate adverse events.
Key Players & Entities
- Liquidia Corporation (company) — Registrant
- March 13, 2024 (date) — Date of earliest event reported
- 419 Davis Drive, Suite 100, Morrisville, North Carolina 27560 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by Liquidia Corporation?
The primary purpose of this 8-K filing is to report on Liquidia Corporation's results of operations and financial condition, as well as to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 13, 2024.
Where are Liquidia Corporation's principal executive offices located?
Liquidia Corporation's principal executive offices are located at 419 Davis Drive, Suite 100, Morrisville, North Carolina 27560.
What is Liquidia Corporation's state of incorporation?
Liquidia Corporation is incorporated in Delaware.
What is the SIC code for Liquidia Corporation?
The Standard Industrial Classification (SIC) code for Liquidia Corporation is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 512 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-03-13 06:14:57
Filing Documents
- tm248678d1_8k.htm (8-K) — 24KB
- tm248678d1_ex99-1.htm (EX-99.1) — 56KB
- 0001104659-24-033684.txt ( ) — 260KB
- lqda-20240313.xsd (EX-101.SCH) — 3KB
- lqda-20240313_lab.xml (EX-101.LAB) — 33KB
- lqda-20240313_pre.xml (EX-101.PRE) — 22KB
- tm248678d1_8k_htm.xml (XML) — 3KB
02
Item 2.02 Results of Operations and Financial Condition. On March 13, 2024, Liquidia Corporation, a Delaware corporation, issued a press release announcing its financial results for the full year ended December 31, 2023, and also provided a corporate update. A copy of the press release is furnished herewith as Exhibit 99.1.*
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibit No. Exhibit 99.1 Press Release of Liquidia Corporation, dated March 13, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * The information in Item 2.02 of this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. March 13, 2024 Liquidia Corporation By: /s/ Michael Kaseta Name: Michael Kaseta Title: Chief Financial Officer and Chief Operating Officer